|Articles|April 1, 2012
- Applied Clinical Trials-04-01-2012
- Volume 21
- Issue 4
Applied Clinical Trials Digital Edition - April 2012
INFORMATION TECHNOLOGY : Enhancing Risk Assessment and Mitigation REGULATORY : Sunshine Act?s Impact on the Industry Implementation of Objective Internal Monitoring Also in this issue : Impact of Transparency Policies, EMA?s Executive Director Faces Multiple Challenges, The Roles of Healthcare and Research, HIV Vaccine Trials
Advertisement
Articles in this issue
about 14 years ago
Business and News Update April 2012about 14 years ago
Transparency, Sunshine Shape Researchabout 14 years ago
When Worlds Collide: Healthcare and Researchabout 14 years ago
CRO Founded to Address Neglected Diseases in Under Served Countriesabout 14 years ago
EFGCP Acts to Reduce Ethics Problemsabout 14 years ago
Sunshine Act's Impactabout 14 years ago
Keeping a Cool Head Amidst Turmoilabout 14 years ago
Startup Offers New Take on Recruitmentabout 14 years ago
Risk Assessment and MitigationAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
PLPS Launches MyClinicalSuite™ to Deliver Faster Clinical Trial Label Turnarounds Without Compromising Quality, Compliance, or Patient Safety
2
Quantifying the Net Financial Value of Deploying Risk-Based Quality Management
3
ACT Brief: RBQM Financial Value Quantified, Sponsor-Configurable AI Systems, and Basket Trials for Rare Pediatrics
4
AI-Driven Clinical Trial Recruitment and Design
5